NeoGenomics, Inc. (NEO) Dividend History

NeoGenomics, Inc. is a biotechnology company specializing in cancer genetics testing and clinical trial services. It focuses on providing advanced molecular testing and diagnostic services to oncologists, pharmaceutical companies, and researchers to improve cancer detection, diagnosis, and treatment. Founded in 2002, the company operates labs across the United States and is committed to innovation in cancer genomics.

9490 Neogenomics Way, Fort Myers, FL, 33912
Phone: (239) 768-0600
Website: https://www.neogenomics.com

Dividend History

NeoGenomics, Inc. currently does not pay dividends

Company News

It's Not Too Late to Jump on These Under-the-Radar Momentum Plays

Three stocks across multiple sectors may draw the attention of investors looking for a momentum play - Oddity Tech Ltd, NeoGenomics Inc, and Comfort Systems USA Inc. These companies have seen significant share price improvements and positive analyst ratings, suggesting potential for continued upside.

Investing.com

Featured Companies: FIX ODD
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

The Minimal Residual Disease (MRD) Testing Market is expected to grow at a CAGR of 11.18% from 2025 to 2030, driven by advancements in diagnostic technologies and the increasing focus on precision medicine and early relapse detection.

GlobeNewswire Inc.

Featured Companies: ADPT AMGN BIO BIO.B BMY DGX EXAS GH GILD ILMN LH MDXH MYGN NTRA OPK TECH VCYT
Not Just a DEX: How Pineapple’s Mystery Marketing is Changing the Game

Pineapple is a next-generation decentralized exchange that combines AI-driven community interaction, cutting-edge trading tools, and a unique narrative-driven marketing approach to revolutionize DeFi trading and engagement.

GlobeNewswire Inc.

Featured Companies: AMZN BSY COIN DIS KO NKE UA UAA
Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

The article discusses the promising developments in cancer research, including new therapies and innovative technologies, and highlights recent updates from several biotech companies working on cutting-edge cancer treatments.

Benzinga

Featured Companies: ADPT ELEV ONCY ORIC
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology

The global gene panel market is projected to reach $11.75 billion by 2031, growing at a CAGR of 19.30% during the forecast period. The market growth is driven by advancements in genomic research, rising prevalence of genetic disorders, and growing awareness of genetic testing.

GlobeNewswire Inc.

Featured Companies: A BDX BIO BIO.B CSTL GH ILMN MYGN PKI PSNL QGEN SGMO TEM TMO TWST

Dividend data last updated 06/07/2025 02:00:12 UTC